Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium voltage-gated channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"kidney: 123.2"	"Cell line enriched"	"Detected in some"	40	"RPTEC TERT1: 50.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.3"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced									"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.1	0.0	0.5	0.2	2.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	123.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium voltage-gated channel subfamily J member 10"	P78508	1	159998651-160070483	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.1;kidney: 28.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.4;SK-MEL-30: 3.6;U-266/70: 3.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.7;T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced									"HPA078302: "	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	1.4	1.5	23.6	3.0	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0.0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2.0	1.8	25.5	0.0	1.5	0.0	2.9	1.5	0.1	0.0	0.0	0.0	0.3	1.7	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.2	1.7	0.2	0.0	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	11.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	2.1	0.1	0.0	0.0	0.2	0.4	0.0	0.3	3.6	0.1	0.5	0.1	0.1	0.3	0.9	0.0	3.7	1.7	0.0	0.2	0.2	1.7	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	1.7	0.3	0.0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium voltage-gated channel subfamily J member 11"	Q14654	11	17385859-17389331	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 63.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;HEK 293: 13.4;MCF7: 10.7;SCLC-21H: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048891	Approved									"HPA048891: "	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favourable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.5	1.1	2.9	1.0	7.8	0.8	2.7	13.6	7.8	1.0	1.1	0.7	4.9	1.4	1.1	2.1	1.7	1.1	1.1	6.2	3.5	2.4	1.3	0.9	1.3	1.2	2.7	5.2	0.8	8.7	2.7	3.3	0.7	3.5	2.5	1.0	0.1	1.2	7.6	63.1	1.0	1.1	0.8	1.7	1.0	4.6	0.8	1.9	0.0	4.1	4.5	1.0	0.9	1.1	0.8	0.4	1.4	0.3	0.8	0.4	0.4	1.5	2.3	0.3	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	2.5	0.2	7.1	0.2	0.0	0.3	4.8	0.1	0.3	1.6	13.4	3.6	0.9	0.8	0.1	0.4	0.3	0.1	0.3	0.0	0.1	0.0	3.7	3.8	0.0	10.7	0.7	0.1	1.0	0.3	1.4	1.7	2.0	0.4	0.9	9.1	0.8	0.0	3.5	0.0	4.6	0.2	0.0	0.0	1.2	0.0	0.1	0.2	6.0	0.9	0.0	1.0	0.0	1.4	0.3	0.2	0.4	0.3	0.3	0.7	0.4	0.4	0.1	0.8	0.4	0.4	1.3	0.8	0.1	0.4	0.3	0.4	2.9	7.8	13.6	7.8	3.5	2.4	2.7	5.2	3.5	1.9
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium voltage-gated channel subfamily J member 12"	Q14500	17	21376197-21419872	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 39.4;skeletal muscle: 47.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.7;HeLa: 6.2;PC-3: 6.5;SCLC-21H: 7.6;SiHa: 3.8;U-2197: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 39.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4.0	0.9	0.6	1.7	0.6	0.9	47.8	6.0	0.6	1.0	0.9	1.3	0.9	1.3	0.9	0.0	1.0	7.5	1.1	0.8	1.5	0.0	0.9	0.0	0.5	0.0	0.1	0.0	0.0	1.1	0.4	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	3.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	1.5	6.5	0.0	1.0	1.7	0.0	0.0	7.6	0.4	3.8	0.0	1.6	0.0	0.0	2.9	0.0	0.5	6.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4.0	0.9
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;CACO-2: 2.7;U-2197: 4.7"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.3	0.2	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.2	0.3	0.0	0.1	0.0	4.7	0.4	1.4	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium voltage-gated channel subfamily J member 14"	Q9UNX9	19	48455509-48466980	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9"	"Cell line enhanced"	"Detected in many"		"NB-4: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA071765			Approved	Nucleoli				Nucleoli		"HPA071765: "	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.33e-5)"	"unprognostic (5.77e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.05e-4)"	"unprognostic (7.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.02e-6)"	"unprognostic (1.47e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.82e-3)"	"unprognostic (4.41e-2)"	1.0	0.4	1.1	0.9	6.1	4.9	1.8	2.3	2.2	0.9	0.9	0.9	0.9	0.6	0.9	1.8	1.5	1.1	1.0	0.9	1.4	1.3	0.9	0.9	0.9	1.2	1.2	0.9	1.3	1.4	1.0	1.0	1.4	1.4	1.5	0.7	22.9	0.9	0.9	3.3	4.9	0.9	0.9	0.9	0.9	0.6	2.8	0.9	0.9	1.6	0.9	0.9	0.9	1.1	1.5	0.8	3.5	0.8	0.6	1.0	0.2	1.6	3.8	0.8	2.5	1.7	1.6	2.5	0.6	0.3	0.8	1.2	3.8	2.2	1.8	0.8	0.6	5.3	1.2	0.6	2.0	1.3	2.0	1.1	2.1	1.0	0.9	1.5	3.1	1.5	2.8	1.9	2.2	0.5	1.8	1.9	0.5	2.3	0.6	12.2	1.4	2.1	2.5	1.5	0.4	0.6	4.5	1.4	1.7	1.7	2.5	1.3	1.7	1.3	1.0	2.7	3.5	2.6	3.0	2.0	3.0	1.3	0.7	3.9	2.8	3.5	0.8	0.6	0.6	0.6	0.5	1.2	0.7	1.0	0.4	1.5	0.8	1.0	2.9	0.6	0.3	0.8	0.6	0.2	1.1	6.1	2.3	2.0	1.4	1.3	1.2	0.9	1.4	0.9
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium voltage-gated channel subfamily J member 15"	Q99712	21	38155549-38307357	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 74.8;kidney: 99.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 28.0;HBEC3-KT: 26.9;LHCN-M2: 12.3;RPTEC TERT1: 26.8;RT4: 31.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	21	"neutrophil: 74.8"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 74.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favourable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favourable (1.95e-4)"	6.0	0.3	0.4	5.3	0.3	3.2	1.4	0.2	0.3	3.5	0.4	0.2	27.1	0.2	0.5	12.8	6.0	0.8	17.7	1.0	0.2	0.1	99.7	1.5	34.1	0.8	0.5	0.2	0.6	16.7	0.0	0.3	1.0	0.6	4.0	0.0	0.2	14.4	26.8	1.0	1.7	0.2	0.9	0.4	6.8	10.7	1.1	0.2	0.4	36.8	3.2	1.9	11.3	4.3	0.0	0.2	74.8	3.5	0.0	0.0	0.7	0.6	0.0	0.1	0.2	5.5	28.0	0.2	0.4	1.9	0.0	0.0	0.0	0.2	0.1	0.0	2.9	9.4	0.0	26.9	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	8.2	2.7	7.0	1.5	1.3	0.1	0.2	12.3	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	26.8	31.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.1	1.4	0.0	0.7	0.1	0.0	2.2	1.6	0.1	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	0.7	0.4	0.3	0.2	0.3	0.2	0.1	0.5	0.2	0.6	0.2
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium voltage-gated channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4"	"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 78.9"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles				Vesicles		"HPA059563: "	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (6.58e-4)"	"unprognostic (3.88e-1)"	0.4	0.3	4.1	0.3	4.4	0.4	1.5	22.6	6.1	0.3	0.4	1.7	12.6	0.4	0.4	6.4	0.3	2.0	6.5	0.4	6.0	7.2	96.5	0.9	0.5	0.4	8.3	3.4	0.4	15.8	59.4	0.8	0.5	25.5	1.0	0.3	0.0	4.1	14.3	0.4	0.5	1.2	0.2	7.5	1.1	7.4	0.8	5.3	0.0	60.4	0.0	0.2	0.3	0.3	1.1	0.5	5.1	0.2	0.9	1.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	78.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.9	0.1	1.2	1.0	1.0	0.5	0.1	1.1	0.7	0.6	5.1	0.9	0.1	0.5	1.1	0.3	4.1	4.4	22.6	6.1	6.0	7.2	8.3	3.4	25.5	5.3
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium voltage-gated channel subfamily J member 2"	P63252	17	70168673-70180048	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;parathyroid gland: 34.8"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 5.1;REH: 6.0;RH-30: 24.2;U-138 MG: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 20.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029109	Approved									"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	3.0	1.5	6.2	6.3	17.9	2.5	6.6	1.3	12.8	1.8	5.0	23.7	5.1	1.6	1.5	1.2	4.7	8.4	2.2	11.4	6.4	4.4	1.7	1.9	3.9	4.4	22.4	8.5	1.4	1.0	34.8	1.6	9.0	11.7	2.6	4.3	3.1	2.7	2.9	10.3	6.0	2.1	1.6	14.9	10.4	2.0	0.9	18.2	0.5	1.9	6.0	2.2	2.6	3.3	0.1	0.7	20.8	4.7	0.0	0.0	0.4	0.0	0.7	1.5	0.0	1.6	0.4	0.0	0.5	3.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.5	0.0	4.6	0.0	0.0	1.7	0.1	2.3	0.2	5.1	0.0	0.0	1.5	0.0	0.5	0.0	0.1	0.1	6.0	24.2	0.0	0.6	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.4	0.1	8.9	0.1	0.0	1.9	0.0	0.0	0.1	1.9	0.0	1.2	1.8	2.5	3.6	0.0	4.7	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	20.8	0.0	4.6	0.1	0.0	0.4	6.2	17.9	1.3	12.8	6.4	4.4	22.4	8.5	11.7	18.2
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium voltage-gated channel subfamily J member 3"	P48549	2	154698299-154858352	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;parathyroid gland: 22.1"	"Cell line enhanced"	"Detected in some"		"BJ: 5.3;SH-SY5Y: 3.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Region enhanced"	"Detected in many"		"cerebellum: 33.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA024231	Uncertain									"HPA024231: AB_1855558"	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.3	1.0	4.5	0.0	3.4	0.0	0.2	33.8	13.6	1.3	1.5	1.4	0.3	7.9	0.2	0.9	0.1	0.4	0.9	10.8	8.4	4.0	8.0	2.3	0.2	0.4	1.8	4.9	0.2	1.5	22.1	9.0	0.0	3.0	5.1	0.6	1.0	0.1	9.2	3.5	0.2	6.7	0.1	1.5	0.4	0.5	0.2	0.9	0.0	0.2	0.0	0.0	0.5	0.6	1.2	0.9	3.3	1.1	1.8	1.0	0.4	0.2	0.3	0.0	0.1	0.2	0.1	0.4	5.3	0.2	0.0	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.8	0.0	0.7	0.5	0.5	0.1	0.0	0.4	0.2	0.3	1.7	3.3	0.1	0.5	0.2	0.4	0.1	0.0	0.3	0.4	0.4	0.3	0.3	0.2	0.1	1.2	0.2	0.5	3.3	0.7	0.9	0.7	0.8	0.9	1.0	0.9	0.6	0.6	1.2	1.0	0.9	1.9	1.8	1.1	0.9	0.7	0.4	4.5	3.4	33.8	12.0	8.4	4.0	1.8	4.9	3.0	0.9
KCNJ4	"HIR, hIRK2, HRK1, IRK3, Kir2.3"	ENSG00000168135	"Potassium voltage-gated channel subfamily J member 4"	P48050	22	38426327-38455199	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 25.9;heart muscle: 16.9"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 15.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"amygdala: 105.8;basal ganglia: 143.6;cerebral cortex: 111.8;hippocampal formation: 85.7;olfactory region: 150.7"	"Group enriched"	"Detected in many"	14	"amygdala: 32.2;basal ganglia: 63.2;cerebral cortex: 71.1;hippocampal formation: 59.7;olfactory region: 117.2"													"unprognostic (4.76e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.07e-1)"		"unprognostic (3.15e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.41e-2)"		0.1	0.2	9.9	0.1	17.9	0.1	0.1	0.0	25.9	0.1	0.1			0.3	0.1	0.1	0.1	0.7	0.8	16.9	9.4	1.7	0.2	0.4	0.1	0.1	0.7		0.1	0.2	0.1	0.0	0.1		0.1	0.1		0.1	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.5			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	1.1	0.0	0.5	0.0	2.3	0.0	0.1	0.0	0.0	15.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium voltage-gated channel subfamily J member 5"	P48544	11	128891356-128921035	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.7;ductus deferens: 54.6;pituitary gland: 23.4"	"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"basal ganglia: 3.1;hypothalamus: 8.0;midbrain: 2.2;thalamus: 4.0"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Enhanced									"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.8	40.7	0.8	0.3	1.9	0.2	0.9	0.3	1.2	0.8	0.8	1.9	54.6	0.4	0.3	1.1	0.6	0.6	1.3	8.7	1.6	2.5	2.0	0.3	3.4	0.8	3.7	0.8	0.8	16.6	0.7	23.4	4.3	3.4	0.8	0.4	3.3	0.9	21.7	0.3	0.4	0.5	0.7	4.5	7.7	1.5	0.7	0.9	2.3	0.7	0.4	0.3	1.1	0.5	0.9	0.4	2.9	0.7	0.6	0.4	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.4	17.1	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.2	0.1	0.1	1.3	0.0	2.2	0.7	0.6	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.9	0.3	0.4	2.9	0.6	0.4	0.4	0.2	0.4	0.8	1.9	0.3	1.2	1.6	2.5	3.7	0.8	3.4	0.9
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium voltage-gated channel subfamily J member 6"	P48051	21	37607376-38121345	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;pituitary gland: 12.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 25.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	2.0	1.2	7.7	0.9	8.4	1.0	1.1	24.0	15.6	0.9	1.4	0.8	0.0	1.1	1.4	0.6	0.7	0.7	0.8	1.2	14.6	1.1	1.2	0.9	1.0	1.4	1.3	10.8	0.8	2.7	0.7	12.2	7.4	13.5	1.5	0.9	0.0	0.8	0.6	2.2	1.1	1.1	0.5	1.5	1.6	2.7	2.0	0.4	0.0	0.8	0.0	0.6	0.8	0.8	0.3	0.3	4.2	0.3	0.3	0.2	0.0	0.0	0.0	0.6	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.7	1.4	0.0	2.9	0.1	25.0	0.1	0.0	0.0	0.2	2.4	0.0	0.1	0.8	3.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.1	3.7	1.0	0.0	0.0	0.0	0.0	4.2	0.3	3.6	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	2.0	0.3	0.2	0.3	0.1	0.0	7.7	8.4	24.0	15.6	14.6	1.1	1.3	10.8	13.5	0.4
KCNJ8	Kir6.1	ENSG00000121361	"Potassium voltage-gated channel subfamily J member 8"	Q15842	12	21764955-21775581	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 60.1;pancreas: 47.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 41.5;HSkMC: 8.4;SH-SY5Y: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031066	Uncertain									"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	14.6	12.9	3.2	2.7	3.4	0.0	14.7	1.7	5.1	7.7	6.6	2.3	3.6	2.0	10.6	4.5	6.7	5.9	6.3	60.1	2.2	1.7	6.4	29.7	12.4	3.5	2.9	3.0	12.4	47.6	1.7	3.8	4.9	3.7	10.6	1.6	8.8	2.9	15.7	15.0	2.4	3.8	13.2	2.6	3.8	6.5	3.4	2.8	0.9	8.4	7.0	1.2	11.4	5.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	5.1	3.4	0.0	5.6	4.5	6.4	3.3	41.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.9	0.0	2.0	1.3	0.0	0.0	0.1	0.0	0.0	8.4	0.0	2.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.8	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.4	1.7	5.1	2.2	1.7	2.9	3.0	3.7	2.8
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium voltage-gated channel subfamily J member 9"	Q92806	1	160081570-160090563	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"brain: 52.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.8"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced									"HPA070478: "	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	1.4	1.9	15.6	1.4	15.3	1.4	1.4	32.1	52.0	1.4	1.4	11.9	0.0	1.4	1.4	1.4	1.4	1.4	1.4	1.4	18.4	11.1	1.5	1.4	1.4	1.4	18.3	20.6	1.4	1.4	1.4	0.7	1.4	7.4	1.4	1.4	0.0	1.4	1.4	1.4	1.4	1.5	1.4	11.4	1.4	1.5	1.7	11.6	0.0	1.4	0.0	1.4	1.4	0.0	0.8	0.0	0.0	0.3	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	2.3	2.7	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.0	0.5	0.0	2.8	0.2	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.1	0.4	0.2	1.1	0.0	0.8	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	15.6	15.3	32.1	27.2	18.4	11.1	18.3	20.6	7.4	11.6